Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.56ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.56EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDTEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDTECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDTECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDTEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDTEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DH.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used